The Kenya Medical Research Institute is a state corporation established through the Science and Technology Act of 1979, during the tenure of Nicholas Biwott as Minister of State, as the national body responsible for carrying out health research in Kenya.

During the past decade, Kenya Medical Research Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kenya Medical Research Institute" #1 sponsor was "University of Washington" with 4 trials, followed by "Foundation for Innovative New Diagnostics, Switzerland" with 3 trials sponsored, "Duke University" with 2 trials sponsored, "Kenya Medical Research Institute" with 2 trials sponsored and "Barcelona Institute for Global Health" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kenya Medical Research Institute" #1 collaborator was "Kenya Medical Research Institute" with 14 trials as a collaborator, "European and Developing Countries Clinical Trials Partnership (EDCTP)" with 3 trials as a collaborator, "European Vaccine Initiative" with 2 trials as a collaborator, "Imperial College London" with 2 trials as a collaborator and "London School of Hygiene and Tropical Medicine" with 2 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Kenya Medical Research Institute" are "HIV Infections" (3 trials), "Helminthiasis" (3 trials), "Visceral Leishmaniasis" (3 trials), "Cervical Cancer" (2 trials) and "HPV Infection" (2 trials). Many other conditions were trialed in "Kenya Medical Research Institute" in a lesser frequency.

Most popular intervention types in "Kenya Medical Research Institute" are "Drug" (9 trials), "Other" (4 trials), "Behavioral" (3 trials), "Diagnostic Test" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Albendazole" (3 trials), "Placebo" (2 trials), "1. SD Bioline Salmonella Typhi IgG/IgM Fast test, 2. Typhidot Rapid IgG/IgM combo test, 3. TUBEX TF test, 4.Typhoid IgG/IgM Combo Rapid Test CE, 5. Enterocheck WB test, 6. Test-itTM Typhoid IgM test" (1 trials), "Albendazole and Ivermectin fixed dose coformulation" (1 trials) and "Azithromycin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kenya Medical Research Institute" are 19 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Kenya Medical Research Institute". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Kenya Medical Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kenya Medical Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

Kenya Medical Research Institute has several departments that took part in Clinical trials: "KEMRI - Centre for Respiratory Disease Research (CRDR)" - 2 trials